About This Webinar
Primary hyperparathyroidism (PHPT) is a common endocrine condition which is associated with adverse skeletal outcomes including loss of bone mineral density and increased fracture risk. Surgery (parathyroidectomy) is the only curative option for PHPT and osteoporosis is an indication for this.

With improved diagnostics and recognition, there is a growing prevalence of normocalcaemic PHPT and data on skeletal outcomes are emerging. This talk will cover the impact of PHPT and other forms of hyperparathyroidism on bone health and fracture risk. We will also consider indications for the different therapeutic options.

The handout for this session is available by clicking the handout icon in the bottom right-hand corner of the video player.
Presenter
  • 1624110646-df10e5d5cd9058c6
    Dr Zaki Hassan-Smith
    Honorary Consultant Endocrinologist, University Hospitals Birmingham NHS Foundation Trust & Clinical Senior Lecturer, Aston Medical School

    Zaki Hassan-Smith is a consultant endocrinologist at University Hospitals Birmingham NHS Foundation Trust with a sub-speciality interest in metabolic bone disease. He leads the osteogenesis imperfecta/ bone genetics service and the clinical research programme. He is Clinical Senior Lecturer at Aston University Medical School and an honorary clinical senior lecturer at the University of Birmingham. He holds an NIHR CRN funded research scholarship and is Principal Investigator on interventional studies of patients with parathyroid disease.

    Previous posts include an honorary professorship in health and life sciences at Coventry University; clinical lectureship at the European Research Council and NIHR funded clinical research fellowships in Birmingham. He is an expert contributor to the US-led international task force and the European Endocrine Society Consensus Statement Group for Parathyroid Disease. He completed his PhD on the impact of steroid metabolism on sarcopenia. He trained in London and Birmingham.
Powered by BigMarker